Long Coronary Lesions: Challenging Cases for Percutaneous Coronary Intervention
- 1 Department of Cardiology, Hospital Clínico Universitario, Valencia, Spain
- 2 Department of Cardiology, Hospital Clínico Universitario, Valencia, Spain
- 3 Department of Cardiology, Hospital Clínico Universitario, Valencia, Spain
Abstract
Long coronary lesions are associated with adverse outcomes after percutaneous coronary intervention since the era of plain balloon angioplasty. Long lesion and long stent length are considered as important predictors of restenosis after percutaneous coronary intervention. With the advent of newer generation drug eluting stents, there has been dramatic reduction in the rates of restenosis and repeat revascularization, even in complex cohort of patients with long coronary lesions. We report one such case of long coronary lesion which was intervened successfully with newer generation, thin strut, biodegradable polymer coated sirolimus-eluting stents.
- Serruys, P.W., Foley, D.P., Suttorp, M.-J., Rensing, B.J., Suryapranata, H., Materne, P., et al. (2002) A Randomized Comparison of the Value of Additional Stenting after Optimal Balloon Angioplasty for Long Coronary Lesions: Final Results of the Additional Value of NIR Stents for Treatment of Long Coronary Lesions (ADVANCE) Study. Journal of the American College of Cardiology, 39, 393-399. http://dx.doi.org/10.1016/S0735-1097(01)01760-0
- Triantafyllou, K. (2013) Spot Stenting Is Preferable in Long Diffuse Coronary Lesions: Possible Incremental Value of Physiologic and Intracoronary Imaging Modalities. Hospital Chronicles, 8, 71-77.
- Bauters, C., Banos, J.-L., Van Belle, E., McFadden, E.P., Lablanche, J.-M. and Bertrand, M.E. (1998) Six-Month Angiographic Outcome after Successful Repeat Percutaneous Intervention for In-Stent Restenosis. Circulation, 97, 318-321. http://dx.doi.org/10.1161/01.CIR.97.4.318
- Orlic, D., Stankovic, G., Corvaja, N., Airoldi, F., Montorfano, M., Tavano, D., et al. (2004) 1044-53 Full Metal Jacket in the Drug-Eluting Stent Era: In-Hospital and 30-Day Outcome. Journal of the American College of Cardiology, 43, A45-A.
- Aoki, J., Ong, A.T., Granillo, G.A.R., McFadden, E.P., van Mieghem, C.A., Valgimigli, M., et al. (2005) Full Metal Jacket (Stented Length ≥ 64 mm) Using Drug-Eluting Stents for de Novo Coronary Artery Lesions. American Heart Journal, 150, 994-999. http://dx.doi.org/10.1016/j.ahj.2005.01.050
- Kim, Y.H., Park, S.W., Lee, C.W., Hong, M.K., Gwon, H.C., Jang, Y., et al. (2006) Comparison of Sirolimus-Eluting Stent, Paclitaxel-Eluting Stent, and Bare Metal Stent in the Treatment of Long Coronary Lesions. Catheterization and Cardiovascular Interventions, 67, 181-187. http://dx.doi.org/10.1002/ccd.20586
- Bourassa, M.G., Lespérance, J., Eastwood, C., Schwartz, L., Cöté, G., Kazim, F., et al. (1991) Clinical, Physiologic, Anatomic and Procedural Factors Predictive of Restenosis after Percutaneous Transluminal Coronary Angioplasty. Journal of the American College of Cardiology, 18, 368-376. http://dx.doi.org/10.1016/0735-1097(91)90588-Z
- Menown, I.B. (2013) Very Long Stent Technology: Clinical and Practical Value. Future Cardiology, 9, 641. http://dx.doi.org/10.2217/fca.13.50
- Kereiakes, D.J., Wang, H., Popma, J.J., Kuntz, R.E., Donohoe, D.J., Schofer, J., et al. (2006) Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents: Pooled Analysis of Five Clinical Trials. Journal of the American College of Cardiology, 48, 21-31. http://dx.doi.org/10.1016/j.jacc.2006.02.058